La catena delle opzioni mostra i dati chiave delle opzioni azionarie di PureTech Health a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per PureTech Health..

PureTech Health (NASDAQ:PRTC) Azioni, Catena delle Opzioni

PureTech Health

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

PureTech Health plc - American Depositary Shares

PureTech Health PLC

President Donald Trump has announced that his administration will begin informing trading partners about new tariffs on their exports starting this Friday.
What Happened: These tariffs are scheduled to take effect on August 1. Trump mentioned that approximately &#8220;10 or 12&#8221; letters will be sent out initially, with more to follow in the coming days, according <a href="https://www.bloomberg.com/news/articles/2025-07-03/trump-says-he-may-start-telling-nations-new-tariff-rates-friday">to</a> a Bloomberg report on Friday.
The president stated that by July 9, all countries would be notified of their new tariff levels, which could range from 10% to 70%. This move is part of Trump&#8217;s strategy to favor straightforward agreements over complex negotiations. Negotiations with countries such as Indonesia, South Korea, the European Union, and Switzerland are reaching critical stages.
Trump&#8217;s latest tariff threat is consistent with his previous ultimatums, suggesting that some countries may not have a say in their tariff levels. The highest proposed tariffs could exceed those initially outlined during his &#8220;Liberation Day&#8221; announcement in April, which ranged from 10% to 50%.
Trump emphasized that countries would start paying these tariffs on August 1, with revenue beginning to flow into the US. The impact of these tariffs on inflation has led some Federal Reserve officials to be cautious about cutting interest rates, despite pressure from Trump.
See Also: <a href="https://benzinga.com/markets/equities/25/07/46259886/elon-musks-tesla-is-a-multi-trillion-dollar-opportunity-but-short-term-outlook-is-shaky-says-exp">Elon Musk&#8217;s Tesla Is A &#8216;Multi-Trillion-Dollar Opportunity,&#8217; But Short-Term Outlook Is &#8216;Shaky,&#8217; Says Expert</a>
While deals have been reached with the UK and Vietnam, other major trading partners like Japan and South Korea are still negotiating. Trump remains optimistic about reaching an agreement with India but has criticized Japan as a challenging partner.
Why It Matters: The announcement comes amid escalating trade tensions, notably with Japan. Trump recently threatened to impose tariffs of &#8220;30% or 35%&#8221; on<a href="https://www.benzinga.com/news/politics/25/07/46213186/trump-threatens-35-tariffs-on-japan-as-trade-deadline-looms-not-sure-were-going-to-make-a-deal"> Japanese exports if no agreement</a> is reached by the July 9 deadline, a significant increase from the current 10% rate reported earlier this week.
A trade deal with<a href="https://www.benzinga.com/news/politics/25/07/46241070/trumps-vietnam-trade-deal-with-40-tax-on-transshipments-may-result-in-chinese-backlash-say-economists-they-want-inflation"> Vietnam has been secured</a>, imposing a 20% tariff on Vietnamese exports and a 40% tariff on goods transshipped through Vietnam, particularly targeting Chinese products. This deal grants the US tariff-free access to Vietnam&#8217;s domestic markets.
Furthermore, the Trump administration has reportedly scaled back its<a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46188192/trump-administration-reportedly-scales-back-ambitions-for-comprehensive-trade-deals-before-tariff-deadline"> ambitions for comprehensive trade deals</a>, opting for narrower agreements to avoid reimposing tariffs. This shift aims to reach agreements by the July 9 deadline, marking a departure from the initial plan to secure 90 trade deals during a 90-day pause in reciprocal tariffs.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/07/46263007/elon-musk-backs-warren-buffetts-brutal-5-minute-deficit-fix-to-ban-congress-from-reelection-if-they-blow-the-budget-100-this-is-the-way">Elon Musk Backs Warren Buffett&#8217;s Brutal &#8216;5-Minute Deficit Fix&#8217; To Ban Congress From Reelection If They Blow the Budget: &#8216;100% This Is the Way&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Rawpixel.com / Shutterstock.com

Politics

Trump Says US Will Raise Tariffs To Up To 70% As July 9 Deadline Looms

Australian actor Julian McMahon, known for his roles as Doctor Doom in Fantastic Four and popular series such as Charmed and Nip/Tuck, has passed away at the age of 56.
What Happened: According to a report <a href="https://www.theguardian.com/film/2025/jul/05/julian-mcmahon-dies-aged-56-cause-of-death-fantastic-four-niptuck-charmed">by</a> The Guardian, McMahon passed away in Clearwater, Florida, on Wednesday after battling cancer, a diagnosis that had not been publicly shared.
His wife, Kelly Paniagua, confirmed his death on Friday, expressing her sorrow and admiration for McMahon in a statement to Deadline. She described him as a man who cherished life, family, friends, and his work, and who aimed to bring happiness to others.
See Also: <a href="https://benzinga.com/news/politics/25/07/46256467/gavin-newsom-is-going-to-south-carolina-next-week-to-remind-rural-voters-there-they-arent-forgotten">Gavin Newsom Is Going To South Carolina Next Week To Remind Rural Voters There They Aren&#8217;t Forgotten, Presidential Run In 2028 On The Cards?</a>
Born in Sydney in 1968, McMahon was the son of former Australian Prime Minister Sir William &#8220;Billy&#8221; McMahon. He began his career as a model before transitioning to acting, gaining fame with roles in Australian soap operas and later, American television series.
McMahon&#8217;s portrayal of the villainous Doctor Doom in the Fantastic Four films and his role as Dr. Christian Troy in Nip/Tuck were among his most notable performances. He also starred in FBI: Most Wanted as Jess LaCroix.
Dick Wolf, producer of FBI: Most Wanted, expressed his condolences, calling McMahon&#8217;s death &#8220;shocking news&#8221; and extending sympathies to his family.
Why It Matters: The entertainment industry has recently faced the loss of several iconic figures. Just a few months prior, <a href="https://www.benzinga.com/general/entertainment/25/04/44600140/val-kilmer-legendary-actor-who-played-iceman-in-tom-cruise-starrer-top-gun-dies-at-65">Val Kilmer</a>, known for his role as Iceman in Top Gun, passed away at 65 after battling pneumonia.
Kilmer&#8217;s health had been in decline since a throat cancer diagnosis in 2014, which significantly impacted his career.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/entertainment/25/07/46259093/paramount-plus-slashes-prices-to-0-99-per-month-for-premium-plan-get-showtime-nfl-games-offline-access-for-less-than-2">Paramount Plus Slashes Prices To $0.99 Per Month For Premium Plan: Get Showtime, NFL Games, Offline Access For Less Than $2</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Featureflash Photo Agency / Shutterstock.com

Entertainment

Julian McMahon, Actor Who Played Doctor Doom In Fantastic Four Dies At 56

Lime, the electric bike and scooter rental startup backed by <a href="https://www.benzinga.com/news/25/05/45232992/dub-raises-30m-with-backing-from-uber-ceo-dara-khosrowshahi-robinhood-co-founder-nate-rodland-to-let-users-copy-nancy-pelosis-stock-trades">Uber</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), has hired Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) and JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) to prepare for a U.S. initial public offering expected to launch next year,<a href="https://www.reuters.com/business/uber-backed-electric-bike-startup-lime-hires-banks-us-ipo-sources-say-2025-06-24/"> Reuters</a> reports.
Founded in 2017, Lime operates in more than 280 cities across nearly 30 countries, offering short-term rentals for electric bikes and <a href="https://www.benzinga.com/25/03/44353699/niu-q4-rides-high-on-demand-for-e-scooters-but-gross-margins-decline-amid-higher-costs">scooters</a>. According to Reuters, the San Francisco-based startup has been considering a public listing for several years, but the current uptick in IPO activity may provide a timely window to execute the move.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
<h2 class="wp-block-heading">Lime's Financial Turnaround Gains Investor Attention</h2>
In February, Lime<a href="https://www.businesswire.com/news/home/20250218624910/en/Lime-Delivers-Record-Revenue-and-Profitability-Positive-Free-Cash-Flow-in-2024"> reported</a> a 32% increase in net revenue, reaching $686 million for 2024. The company also confirmed that it was free cash flow positive for the second year in a row, a rare feat in the micromobility sector, which has historically struggled to stay afloat.
Lime CEO Wayne Ting described 2024 as "an exceptional year" for the company, citing strong results across key financial and operational metrics, including record profits and expanded global reach.
&#8220;We grew profits faster than revenue in 2024, posting another record year of results through serving more than 24 million riders in hundreds of communities around the world and bringing Lime to more cities globally,&#8221; Ting said in a statement. &#8220;While we saw record demand in 2024, we're just scratching the surface of micromobility's potential to transform cities and better connect people.&#8221;
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
<h2 class="wp-block-heading">IPO Market Recovery Offers Fresh Opportunity</h2>
According to Reuters, the potential IPO follows a broader rebound in the U.S. public listing market, which raised nearly $27 billion in 2024 so far, a 45% increase compared to the same period last year.
Although the total still falls short of the 2021 record of $177 billion, companies like Circle Internet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), which recently raised over $1 billion through an IPO, have signaled growing investor interest in growth-stage tech firms, Reuters says.
Lime's IPO may test investor sentiment in the micromobility space, where competitors like Bird have filed for bankruptcy in recent years, Reuters reports. Unlike others in its category, Lime received prior investment from Uber and is among the few micromobility firms still pursuing public markets. Uber led a funding round for Lime in 2020, at which time the company was reportedly valued at $510 million.<a href="https://www.reuters.com/business/uber-backed-electric-bike-startup-lime-hires-banks-us-ipo-sources-say-2025-06-24/">&nbsp;</a>
According to Reuters, sources familiar with the matter expect the upcoming IPO to value Lime significantly higher than its last reported valuation, although exact figures have not yet been disclosed.
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">Lime Targets Urban Pollution With 43 Million Car Trip Replacements</h2>
Environmental sustainability remains a core focus for Lime as it scales globally. According to the company, Lime riders helped avoid an estimated 20,000 metric tons of CO₂ emissions in the last year by replacing car trips with shared electric vehicles.
Lime estimates its service replaced over 43 million car trips in 2024 and prevented the consumption of roughly 2.2 million gallons of gasoline, equal to approximately 8.5 million liters. The company says it also continues to lower its own operational footprint.
By offering electric scooters and bikes for trips under five miles, Lime says it aims to shift the way urban communities move while supporting city efforts to reduce traffic congestion and meet climate goals.
Read Next: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
Image: Shutterstock

News

CRCL

UBER

Lime's Long-Awaited IPO Is Finally on Track: Uber-Backed Scooter Startup Reports $686M Revenue and 'Cash Flow Positivity'

A 100% disabled veteran with a steady income and growing aches is considering whether to retire now or wait a few more years. In a <a href="https://www.reddit.com/r/retirement/comments/1lmmxv6/should_i_retire_or_wait_a_few_years/">recent post</a> on Reddit's r/retirement forum, he explained his situation: he enjoys his job, but not like he used to. He and his wife bring in $7,500 a month (including her early Social Security benefits), have little savings, and own a home with $350,000 in equity.
He's wondering: Is it wise to walk away from a career now, or should he push through for a couple more years and save $100,000 first?
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
<h2 class="wp-block-heading">Health and Time Are Pressing Concerns</h2>
The veteran mentioned that "life happened," which is why there's not much in savings. However, the couple's medical needs are covered — he has VA benefits, and his wife is on Medicare with supplemental insurance.
Still, health is top of mind. "My body is getting achier every day," he wrote. And for many in similar situations, the question becomes whether it's worth exchanging time and well-being now for more <a href="https://www.benzinga.com/personal-finance/25/03/44504769/suze-orman-says-owning-a-house-is-not-a-retirement-plan-heres-how-to-build-true-financial-security-with-smart-diversification">financial security</a> later.
One Reddit commenter offered this perspective: "You may be trading money you don't need for time you don't get more of." It's a reminder that waiting too long could result in fewer healthy years to enjoy retirement.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
<h2 class="wp-block-heading">Budgeting Is Key to Confidence</h2>
Others pointed out that the missing piece in this veteran's puzzle is a clear picture of his spending. One commenter advised tracking expenses to see whether $7,500 a month would realistically cover their needs. "Our experience is spending doesn&#8217;t naturally go down in retirement," they said. In fact, discretionary spending like travel may even increase.
Another practical suggestion: Try living on that $7,500 budget for six months while still working, and save the rest. This "test run" could offer peace of mind — or highlight unexpected financial gaps.
<h2 class="wp-block-heading">Have a Retirement Plan — Beyond the Finances</h2>
Financials aside, several commenters stressed the importance of knowing what you want to do in <a href="https://www.benzinga.com/real-estate/25/06/46159787/dave-ramsey-suggests-pausing-retirement-savings-to-speed-up-home-down-payment-warns-dont-borrow-from-or-cash-out-your-retirement-accounts-to-speed-up-your-down-payment-savings">retirement</a>, not just when to start it. "Make sure you retire to something — golf, garden, fishing, and your community," one said. "Don't just retire."
Another added: "No reason to retire unless you&#8217;re clear on how you&#8217;ll spend your time every day." Having a strong sense of purpose can make the transition smoother and more fulfilling.
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">Downsizing Could Unlock Cash</h2>
The couple's $350,000 in home equity may become a powerful resource, especially if they choose to downsize. Selling the home could provide a financial buffer and reduce living costs — but that plan may take time to execute, and <a href="https://www.benzinga.com/news/politics/25/06/46162886/us-housing-market-is-not-just-broken-its-rigged-says-craig-shapiro-as-mamdani-vows-to-build-200000-publicly-subsidized-homes-freeze-rent-in-nyc">housing markets</a> can fluctuate.
<h2 class="wp-block-heading">Final Thoughts</h2>
This veteran's situation reflects a common dilemma: Should you step away from work when it starts taking a toll on your body — or push through a few more years to build more financial security?
There's no one-size-fits-all answer, but some strategies — like tracking spending, test-driving your retirement budget, and thinking ahead about lifestyle goals — can make the decision easier.
As one commenter put it, "You'll know when you're ready." But doing the math and making a plan could help that moment arrive with confidence instead of concern.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

'My Body's Getting Achier Every Day': Disabled Veteran With $7,500 Monthly Income And No Savings — Should He Retire Or Wait 3 More Years?

O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) has outperformed the market over the past 15 years by 12.94% on an annualized basis producing an average annual return of 25.36%. Currently, O'Reilly Automotive has a market capitalization of $78.05 billion. 
Buying $100 In ORLY: If an investor had bought $100 of ORLY stock 15 years ago, it would be worth $2,973.63 today based on a price of $91.30 for ORLY at the time of writing.
<h3>O'Reilly Automotive's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751672711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ORLY

Here's How Much You Would Have Made Owning O'Reilly Automotive Stock In The Last 15 Years

Somnigroup International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGI#NYSE">SGI</a>) has outperformed the market over the past 15 years by 3.36% on an annualized basis producing an average annual return of 15.78%. Currently, Somnigroup International has a market capitalization of $14.99 billion. 
Buying $1000 In SGI: If an investor had bought $1000 of SGI stock 15 years ago, it would be worth $8,939.05 today based on a price of $71.87 for SGI at the time of writing.
<h3>Somnigroup International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751670914_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Somnigroup International 15 Years Ago Would Be Worth This Much Today

More than a decade ago, Warren Buffett said the national deficit could be <a href="https://www.benzinga.com/personal-finance/25/02/43904075/warren-buffett-said-he-could-end-u-s-deficit-in-5-minutes-if-you-guys-cant-get-it-done-well-get-some-other-guys-to-get-it-done">solved in just five minutes</a>. His plan? "You just pass a law that says that any time there is a deficit of more than 3% of GDP, all sitting members of Congress are ineligible for reelection."
That 2011 quote, from an interview with <a href="https://www.cnbc.com/2011/07/07/warren-buffetts-5minute-plan-to-fix-the-deficit.html">CNBC's Becky Quick</a>, resurfaced in early June — and this time, it gained traction with one of the world's most influential voices.
On June 4, Utah Sen. Mike Lee (R-UT) <a href="https://x.com/BasedMikeLee/status/1930222931377844568">posted the clip on X</a> and asked, "Would you support this amendment?" Elon Musk didn't hesitate. He <a href="https://x.com/elonmusk/status/1930298268661232083">reposted it</a> with the words "100%" and "This is the way," signaling full endorsement of Buffett's blunt solution.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
The idea, while simple on its face, taps into longstanding frustration over congressional accountability and ballooning debt. Buffett originally framed the plan as a tongue-in-cheek solution to Washington gridlock, but made it clear he believed politicians would act faster if their jobs were on the line.
"I can end the deficit in five minutes," he told Quick at the time. "It's just that simple."
Back in 2011, the U.S. <a href="https://www.cbo.gov/publication/42532">deficit hovered just over $1 trillion</a>, about 8.5% of GDP. Today, it's projected to top $1.9 trillion — or roughly 6.7% of GDP. By Buffett's rule, Congress would have long since cleared out.
Lee, who reposted the clip on X, seemed to agree — and has hinted at wanting to turn it into real policy. In fact, several of his <a href="https://x.com/basedmikelee/status/1930454376000217304">recent posts call for stricter balanced budget</a> measures and constitutional amendments to force fiscal discipline. But translating Buffett's viral soundbite into actual legislation would require a two-thirds majority in both chambers or a convention of states — a high bar in any political climate.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
Musk's endorsement of the idea adds fuel, though. His ability to move public opinion — and occasionally policy discussion — with a single post has made him one of the most unpredictable influencers in politics, even without holding office.
The Buffett clip is gaining renewed momentum among fiscal hawks and frustrated taxpayers alike. And while Buffett may have said it half in jest, the message still lands with a punch: if lawmakers were held personally accountable for the budget, the deficit might not be a recurring headline.
Buffett and Musk <a href="https://www.benzinga.com/news/25/03/44075038/warren-buffett-says-he-has-spoken-to-elon-musk-a-few-times-but-repeatedly-dodges-questions-about-tesla-ceos-doge-efforts-well-i-better-not-get-into-all-that">haven't always been aligned</a>. Buffett famously declined to invest in Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), favoring Chinese automaker BYD instead. Musk, in turn, has publicly taken jabs at Buffett. "To be totally frank, I'm not his biggest fan," Musk told Joe Rogan on "<a href="https://youtu.be/RcYjXbSJBN8?si=AHItbBcTYYxDeQ-F">The Joe Rogan Experience</a>" in 2020. "He does a lot of capital allocation… reads a lot of annual reports… it's pretty boring, really."
But on this, they agree. Both men see congressional accountability as key to fixing the deficit—and Musk's viral repost gave Buffett's decade-old solution a jolt of relevance in today's debate.&nbsp;
Read Next:
<ul class="wp-block-list">
<li>Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

TSLA

Elon Musk Backs Warren Buffett's Brutal '5-Minute Deficit Fix' To Ban Congress From Reelection If They Blow the Budget: '100% This Is the Way'

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) has outperformed the market over the past 15 years by 8.14% on an annualized basis producing an average annual return of 20.56%. Currently, Gartner has a market capitalization of $30.81 billion. 
Buying $100 In IT: If an investor had bought $100 of IT stock 15 years ago, it would be worth $1,622.54 today based on a price of $400.28 for IT at the time of writing.
<h3>Gartner's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751670013_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Gartner 15 Years Ago Would Be Worth This Much Today

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 20 years by 5.95% on an annualized basis producing an average annual return of 14.45%. Currently, AMETEK has a market capitalization of $42.50 billion. 
Buying $1000 In AME: If an investor had bought $1000 of AME stock 20 years ago, it would be worth $14,702.96 today based on a price of $184.19 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751668212_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

American Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFG#NYSE">AFG</a>) has outperformed the market over the past 5 years by 2.29% on an annualized basis producing an average annual return of 17.07%. Currently, American Financial Group has a market capitalization of $10.64 billion. 
Buying $100 In AFG: If an investor had bought $100 of AFG stock 5 years ago, it would be worth $208.70 today based on a price of $127.43 for AFG at the time of writing.
<h3>American Financial Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751667312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning American Financial Group Stock In The Last 5 Years

Monolithic Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) has outperformed the market over the past 10 years by 20.06% on an annualized basis producing an average annual return of 31.86%. Currently, Monolithic Power Systems has a market capitalization of $37.01 billion. 
Buying $1000 In MPWR: If an investor had bought $1000 of MPWR stock 10 years ago, it would be worth $15,410.12 today based on a price of $758.66 for MPWR at the time of writing.
<h3>Monolithic Power Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751666424_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MPWR

Here's How Much You Would Have Made Owning Monolithic Power Systems Stock In The Last 10 Years

In the current session, the stock is trading at $175.01, after a 1.48% spike. Over the past month, Fiserv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) stock increased by 5.30%, and in the past year, by 16.27%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1751666417_0.png" alt="Past Year Chart" />

<h3>Fiserv P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 35.47 in the Financial Services industry, Fiserv Inc. has a lower P/E ratio of 30.52. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751666417_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: Fiserv

Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>) has outperformed the market over the past 5 years by 11.09% on an annualized basis producing an average annual return of 25.88%. Currently, Cenovus Energy has a market capitalization of $25.40 billion. 
Buying $100 In CVE: If an investor had bought $100 of CVE stock 5 years ago, it would be worth $303.21 today based on a price of $14.00 for CVE at the time of writing.
<h3>Cenovus Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751665511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Cenovus Energy 5 Years Ago Would Be Worth Today

Moodys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) has outperformed the market over the past 10 years by 4.83% on an annualized basis producing an average annual return of 16.64%. Currently, Moodys has a market capitalization of $90.88 billion. 
Buying $1000 In MCO: If an investor had bought $1000 of MCO stock 10 years ago, it would be worth $4,673.45 today based on a price of $505.06 for MCO at the time of writing.
<h3>Moodys's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751663728_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

GFL Environmental (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>) has outperformed the market over the past 5 years by 5.63% on an annualized basis producing an average annual return of 20.42%. Currently, GFL Environmental has a market capitalization of $17.71 billion. 
Buying $100 In GFL: If an investor had bought $100 of GFL stock 5 years ago, it would be worth $255.75 today based on a price of $48.29 for GFL at the time of writing.
<h3>GFL Environmental's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751662815_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

In the current market session, Sherwin-Williams Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) share price is at $354.00, after a 0.42% spike. Moreover, over the past month, the stock decreased by 0.97%, but in the past year, increased by 17.90%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1751662815_0_0.png" alt="Past Year Chart" />

<h3>Sherwin-Williams P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 169.21 in the Chemicals industry, Sherwin-Williams Inc. has a lower P/E ratio of 33.32. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751662815_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

P/E Ratio Insights for Sherwin-Williams

Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) has outperformed the market over the past 5 years by 6.43% on an annualized basis producing an average annual return of 21.21%. Currently, Carvana has a market capitalization of $46.99 billion. 
Buying $100 In CVNA: If an investor had bought $100 of CVNA stock 5 years ago, it would be worth $259.10 today based on a price of $348.00 for CVNA at the time of writing.
<h3>Carvana's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751661917_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVNA

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Liberty Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) has outperformed the market over the past 10 years by 3.34% on an annualized basis producing an average annual return of 15.15%. Currently, Liberty Media has a market capitalization of $25.69 billion. 
Buying $1000 In FWONK: If an investor had bought $1000 of FWONK stock 10 years ago, it would be worth $4,110.90 today based on a price of $103.00 for FWONK at the time of writing.
<h3>Liberty Media's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751661012_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FWONK

$1000 Invested In Liberty Media 10 Years Ago Would Be Worth This Much Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 60.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed up 22.01% at $0.25</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 14.50% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 14.27% at $1.04</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 10.20% at $0.54</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 8.70% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Growth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 8.38% at $1.28</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 7.10% at $0.29</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 3.86% at $0.31</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 3.58% at $0.05</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 25.00% at $0.0009</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 13.04% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 10.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 8.29% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 7.12% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 6.40% at $0.54</li>
<li><a href="https://www.benzinga.com/quote/RIV">Rivernorth Opps Fund</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#NYSE">RIV</a>) shares closed down 4.46% at $12.35</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 4.23% at $0.86</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Movers

BBRRF

BLGVF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CNTMF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

FFNTF

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LVRLF

NWVCF

OILFF

TLRY

UGRO

YCBD

ZDPY

Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 4, 2025

Performance Food Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFGC#NYSE">PFGC</a>) has outperformed the market over the past 5 years by 12.57% on an annualized basis producing an average annual return of 27.36%. Currently, Performance Food Gr has a market capitalization of $13.87 billion. 
Buying $1000 In PFGC: If an investor had bought $1000 of PFGC stock 5 years ago, it would be worth $3,291.48 today based on a price of $88.87 for PFGC at the time of writing.
<h3>Performance Food Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751660113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PFGC

Here's How Much You Would Have Made Owning Performance Food Gr Stock In The Last 5 Years

Press Releases

PureTech Health plc Statement Regarding Press Speculation

PureTech Appoints Peel Hunt as Joint UK Corporate Broker

PureTech Health: Notice of Results

PureTech Announces Annual Results for Year Ended December 31, 2024

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)

PureTech's Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial

PureTech to Present at the Jefferies Global Healthcare Conference

PureTech Health: Results of Annual General Meeting

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

Comments

PureTech Health

PureTech Health (PRTC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO